441 related articles for article (PubMed ID: 28229895)
1. Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update.
Voon V; Napier TC; Frank MJ; Sgambato-Faure V; Grace AA; Rodriguez-Oroz M; Obeso J; Bezard E; Fernagut PO
Lancet Neurol; 2017 Mar; 16(3):238-250. PubMed ID: 28229895
[TBL] [Abstract][Full Text] [Related]
2. Dopamine and reward hypersensitivity in Parkinson's disease with impulse control disorder.
Drew DS; Muhammed K; Baig F; Kelly M; Saleh Y; Sarangmat N; Okai D; Hu M; Manohar S; Husain M
Brain; 2020 Aug; 143(8):2502-2518. PubMed ID: 32761061
[TBL] [Abstract][Full Text] [Related]
3. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
Lhommée E; Klinger H; Thobois S; Schmitt E; Ardouin C; Bichon A; Kistner A; Fraix V; Xie J; Aya Kombo M; Chabardès S; Seigneuret E; Benabid AL; Mertens P; Polo G; Carnicella S; Quesada JL; Bosson JL; Broussolle E; Pollak P; Krack P
Brain; 2012 May; 135(Pt 5):1463-77. PubMed ID: 22508959
[TBL] [Abstract][Full Text] [Related]
4. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.
Voon V; Fernagut PO; Wickens J; Baunez C; Rodriguez M; Pavon N; Juncos JL; Obeso JA; Bezard E
Lancet Neurol; 2009 Dec; 8(12):1140-9. PubMed ID: 19909912
[TBL] [Abstract][Full Text] [Related]
5. Impulse control disorders in Parkinson's disease.
Marques A; Durif F; Fernagut PO
J Neural Transm (Vienna); 2018 Aug; 125(8):1299-1312. PubMed ID: 29511827
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease-related disorders in the impulsive-compulsive spectrum.
Wolters ECh; van der Werf YD; van den Heuvel OA
J Neurol; 2008 Sep; 255 Suppl 5():48-56. PubMed ID: 18787882
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.
Rodriguez-Oroz MC; López-Azcárate J; Garcia-Garcia D; Alegre M; Toledo J; Valencia M; Guridi J; Artieda J; Obeso JA
Brain; 2011 Jan; 134(Pt 1):36-49. PubMed ID: 21059746
[TBL] [Abstract][Full Text] [Related]
8. Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study.
Biundo R; Weis L; Abbruzzese G; Calandra-Buonaura G; Cortelli P; Jori MC; Lopiano L; Marconi R; Matinella A; Morgante F; Nicoletti A; Tamburini T; Tinazzi M; Zappia M; Vorovenci RJ; Antonini A
Mov Disord; 2017 Nov; 32(11):1557-1565. PubMed ID: 28960475
[TBL] [Abstract][Full Text] [Related]
9. Dysfunctional inhibitory control in Parkinson's disease patients with levodopa-induced dyskinesias.
Picazio S; Ponzo V; Caltagirone C; Brusa L; Koch G
J Neurol; 2018 Sep; 265(9):2088-2096. PubMed ID: 29980853
[TBL] [Abstract][Full Text] [Related]
10. Medical management of levodopa-associated motor complications in patients with Parkinson's disease.
Jankovic J; Stacy M
CNS Drugs; 2007; 21(8):677-92. PubMed ID: 17630819
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced impulse control disorders: a review.
Atmaca M
Curr Clin Pharmacol; 2014 Feb; 9(1):70-4. PubMed ID: 24219002
[TBL] [Abstract][Full Text] [Related]
12. Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?
Molina JA; Sáinz-Artiga MJ; Fraile A; Jiménez-Jiménez FJ; Villanueva C; Ortí-Pareja M; Bermejo F
Mov Disord; 2000 Sep; 15(5):869-72. PubMed ID: 11009192
[TBL] [Abstract][Full Text] [Related]
13. Impulse control disorders in Chinese Parkinson's disease patients: the effect of ergot derived dopamine agonist.
Auyeung M; Tsoi TH; Tang WK; Cheung CM; Lee CN; Li R; Yeung E
Parkinsonism Relat Disord; 2011 Sep; 17(8):635-7. PubMed ID: 21705258
[TBL] [Abstract][Full Text] [Related]
14. Impulse Control Disorders in Parkinson's Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management.
Carbone F; Djamshidian A
CNS Drugs; 2024 Jun; 38(6):443-457. PubMed ID: 38613665
[TBL] [Abstract][Full Text] [Related]
15. Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list.
Fusaroli M; Raschi E; Contin M; Sambati L; Menchetti M; Fioritti A; Poluzzi E
Parkinsonism Relat Disord; 2021 Sep; 90():79-83. PubMed ID: 34399162
[TBL] [Abstract][Full Text] [Related]
16. Preliminary evaluation of the DDS-PC inventory: a new tool to assess impulsive-compulsive behaviours associated to dopamine replacement therapy in Parkinson's disease.
Cabrini S; Baratti M; Bonfà F; Cabri G; Uber E; Avanzi M
Neurol Sci; 2009 Aug; 30(4):307-13. PubMed ID: 19513585
[TBL] [Abstract][Full Text] [Related]
17. [Development of dyskinesias induced by treatment for Parkinson's disease: potential role of first exposure to L-DOPA (or phenomenon of priming)].
Damier P; Tremblay L; Féger J; Hirsch EC
Rev Neurol (Paris); 2000 Mar; 156(3):224-35. PubMed ID: 10740093
[TBL] [Abstract][Full Text] [Related]
18. Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation.
Simoni S; Paoletti FP; Eusebi P; Cappelletti G; Filidei M; Brahimi E; Nigro P; Santangelo V; Parnetti L; Calabresi P; Tambasco N
J Parkinsons Dis; 2020; 10(3):927-934. PubMed ID: 32280105
[TBL] [Abstract][Full Text] [Related]
19. Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias.
de la Fuente-Fernández R; Sossi V; Huang Z; Furtado S; Lu JQ; Calne DB; Ruth TJ; Stoessl AJ
Brain; 2004 Dec; 127(Pt 12):2747-54. PubMed ID: 15329355
[TBL] [Abstract][Full Text] [Related]
20. Motor phenotypes, medication and mood: further associations with impulsive behaviours in Parkinson's disease.
Hurt CS; Alkufri F; Brown RG; Burn DJ; Hindle JV; Landau S; Wilson KC; Samuel M;
J Parkinsons Dis; 2014; 4(2):245-54. PubMed ID: 24366927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
